FILTER
FILTERED INTERVIEW RESULTS
Muzaffer Bal
GENERAL MANAGER, ALI RAIF
Ali Raif is one of the oldest Turkish Pharmaceutical companies, and has developed from manufacturing and marketing under license to producing generics and other drugs.
Robert Foster
CEO, HEPION PHARMACEUTICALS
Hepion Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease.
Daniel J O’Connor
PRESIDENT & CEO, ONCOSEC MEDICAL INCORPORATED
OncoSec is a late-stage biotechnology company developing immunotherapy cancer treatments using its plasmid DNA delivery platform.
Manni Kantipudi
CEO, GVK BIO
GVK BIO is a global Contract Research & Development Organization providing drug discovery and development services to the biopharma industry and experiencing rapid growth.
Girish Chovatia
CHAIRMAN AND MANAGING DIRECTOR, AMI LIFE SCIENCES
Ami Life Sciences is research driven generic API manufacturer as well as working on custom synthesis of New Chemical Entities.
Rahul Maheshwari
MANAGING DIRECTOR, DEFI HEALTHCARE
DEFI Healthcare is an Ahmedabad-based pharmaceutical company involved in the manufacturing and supply of a wide range of avant-garde pharmaceuticals to semi-regulated and non-regulated markets across the globe.
Dr. Seyfullah Dağıstanlı & Aytek Dağıstanlı
FOUNDER & BUSINESS DEVELOPMENT MANAGER, DELTAPV
DeltaPV is Turkey’s leading provider of pharmacovigilance in Turkey and exports its services abroad.
Peter Meath
MANAGING DIRECTOR & CO-HEAD OF HEALTHCARE AND LIFE SCIENCES, J.P. MORGAN COMMERCIAL BANKING
.P.Morgan explains the complete ecosystem that it has developed for life science companies, aiming to serve their needs throughout their entire life cycle, from opening a bank account on Day 1, to expanding internationally and through a potential IPO and beyond.
Ferhat Farsi
CEO AND CO-FOUNDER, CINNAGEN
CinnaGen Co. was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology and related fields.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Peru Mining 2024 Pre-Release II
As the second half of 2024 approaches, Peru stands at a crossroads. According to the latest figures, the Democratic Republic of Congo has surpassed Peru as the second-largest copper producer. Cabinet changes under Boluarte's administration and ongoing corruption cases have taken a toll on investor confidence, and illegal mining remains a pressing issue. However, not everything is lost for the Andean country, and the mining sector presents growth opportunities.
As the second half of 2024 approaches, Peru stands at a crossroads. According to the latest figures, the Democratic Republic of Congo has surpassed Peru as the second-largest copper producer. Cabinet changes under Boluarte's administration and ongoing corruption cases have taken a toll on investor confidence, and illegal mining remains a pressing issue. However, not everything is lost for the Andean country, and the mining sector presents growth opportunities.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
